Concepedia

Author

Philippe Prokocimer

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

P G Prokocimer, P G. Prokocimer, P Prokocimer, P. G. Prokocimer, P. PROKOCIMER, P. Prokocimer, PHILIPPE G. PROKOCIMER, PHILIPPE PROKOCIMER, Philippe G. Prokocimer, Philippe Prokocimer

91

Publications

3.5K

Citations

29

H-Index

72

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Biostatistical Consulting (United States)Cubist Pharmaceuticals (United States)Arcturus Therapeutics (United States)Albany College of Pharmacy and Health Sciences
PP

About

Philippe Prokocimer is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

20

1.3K

2

Health Sciences

8

8

547

3

Natural Sciences

2

2

192

4

Anesthesia

2

2

55

5

Applied Physiology

1

1

39

Philippe Prokocimer

×

47

Publications

3.2K

Citations

27

H-Index

YearCitations

Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections

Philippe Prokocimer, Carisa De Anda, Edward Fang,

JAMA

2013

352

Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial

Gregory J. Moran, Edward Fang, G. Ralph Corey,

The Lancet Infectious Diseases

2014

301

Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study*

Jean Chastre, Richard G. Wunderink, Philippe Prokocimer,

Critical Care Medicine

2008

241

Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial.

W. L. Peterson, David Y. Graham, Barry J. Marshall,

PubMed

1993

216

Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections

Andrew F. Shorr, Thomas P. Lodise, G. Ralph Corey,

Antimicrobial Agents and Chemotherapy

2014

140

Inhalation Toxicity Study of a Haloalkene Degradant of Sevoflurane, Compound A (PIFE), in Sprague-Dawley Rats

K. Keller, Clair M. Callan, Philippe Prokocimer,

Anesthesiology

1995

136

Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study

Álvaro Réa-Neto, Michael S. Niederman, Suzana Margareth Lobo,

Current Medical Research and Opinion

2008

119

Phase 2, Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections

Philippe Prokocimer, Paul Bien, Joseph Surber,

Antimicrobial Agents and Chemotherapy

2010

116

<i>In Vitro</i> , <i>In Vivo</i> , and Clinical Studies of Tedizolid To Assess the Potential for Peripheral or Central Monoamine Oxidase Interactions

Shawn D. Flanagan, Ken Bartizal, Sonia L. Minassian,

Antimicrobial Agents and Chemotherapy

2013

100

Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug

Shawn D. Flanagan, Paul Bien, Kelly A. Muñoz,

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

2013

93

Page 1